The Company benefits
from an interdisciplinary technical team comprising
electronics, biochemistry and microfluidics. With research
and development facilities located at the Institute
of Biomedical Engineering, Imperial College London,
and commercial offices in London’s midtown, the
Board of Directors reflects expertise ranging from diagnostics
to the pharmaceutical industries.
Board of Directors
Prof Chris Toumazou, FRS, FIEEE, FIEE, PhD, CEng
Chairman and Chief Executive Officer
James E Oury LLB ACA
General Counsel
Patrick Stephansen
Interim Chief Financial Officer
Dr Leila Shepherd
Chief Technology Officer
Prof Tony Cass, DPhil, FRSC, CSci, CChem
Director of Technology, specialising in Biochemistry
Dr Rob Fenton
Director of Technology, specialising in Pharmacogenomics
Mitch Cybulski
Non-Executive Director
Scott Young
Non-Executive Director
Dr Sunil Purushothaman
Non-Executive Director
|
Professional Advisors
Corporate:
Cooley Godward Kronish LLP
Legal:
Oury Clark Solicitors
Marks & Clerk
Synnestvedt & Lechner LLP
Financial:
Oury Clark Chartered Accountants
Svenska Handelsbanken
|
|
